Bluejay Diagnostics, Inc. (BJDX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bluejay Diagnostics, Inc., a Delaware corporation and emerging growth company, on October 25, 2022. The report addresses a regulatory notification received from The NASDAQ Stock Market LLC regarding the Company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the status of the Company's stock listing.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On October 25, 2022, the Company received a notification that its common stock closing bid price had been below $1.00 for 30 consecutive business days.
- Rule Violation: This deficiency constitutes non-compliance with Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market.
- Immediate Effect: The notification has no immediate effect on the listing of the Company's common stock.
Outlook, Risks, and Management Commentary
Compliance Timeline: The Company has an initial period of 180 calendar days (until April 24, 2023) to regain compliance. To do so, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days.
Secondary Compliance Period: If the Company fails to regain compliance by April 24, 2023, it may be eligible for an additional 180 calendar days, provided it meets the market value of publicly held shares requirement and all other initial listing standards (except the bid price requirement).
Risks and Contingencies:
- If the Company cannot cure the deficiency during the second compliance period, Nasdaq will issue a notice of delisting.
- The Company may appeal a delisting determination, but there is no assurance that Nasdaq will grant continued listing.
- Management intends to take all reasonable measures to achieve compliance, but there is no assurance that the Company will be able to regain compliance with the minimum bid price requirement or other listing criteria.
Investor Verification Checklist
- Verify the current closing bid price of BJDX common stock to assess progress toward the $1.00 threshold.
- Monitor the Company's stock price for ten consecutive business days above $1.00 to confirm potential compliance.
- Review upcoming filings for any notice of intent to utilize the second 180-day compliance period if the initial deadline is missed.
- Check for any subsequent Nasdaq communications regarding the Company's market value of publicly held shares if a second compliance period is sought.